Hytrin en es it fr

Hytrin Brand names, Hytrin Analogs

Hytrin Brand Names Mixture

  • No information avaliable

Hytrin Chemical_Formula


Hytrin RX_link


Hytrin fda sheet

Hytrin FDA

Hytrin msds (material safety sheet)

Hytrin Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Hytrin Molecular Weight

387.433 g/mol

Hytrin Melting Point

273 oC

Hytrin H2O Solubility


Hytrin State


Hytrin LogP


Hytrin Dosage Forms


Hytrin Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Hytrin Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Hytrin Absorption

Essentially completely absorbed in man (90% bioavailability).

Hytrin side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Hytrin Patient Information

Hytrin Organisms Affected

Humans and other mammals